利用P2-CHA2DS2-VASc评分优化房颤相关卒中的预测
该研究基于ARIC和MESA队列中房颤且未抗凝的参与者,发现异常P波电轴是唯一与缺血性卒中风险独立相关的P波指标,将其加入CHA2DS2-VASc评分(赋2分)形成P2-CHA2DS2-VASc评分,可改善房颤相关缺血性卒中的预测。
要点
- 异常P波电轴独立增加房颤患者缺血性卒中风险(HR 1.84, 95%CI 1.33-2.55)。
- P2-CHA2DS2-VASc评分在ARIC和MESA队列中均提高了卒中预测的C统计量。
- 异常P波电轴是心电图上左房异常的标志,有助于识别高危房颤患者。
核心结论
- 异常P波电轴可改善房颤患者缺血性卒中的预测,P2-CHA2DS2-VASc评分优于CHA2DS2-VASc评分。
研究设计与样本
- 研究纳入ARIC研究的2229例和MESA研究的700例房颤参与者,均未在房颤诊断后1年内抗凝。
- P波指标来自房颤发生前的研究访视心电图,卒中事件由医生判定。
主要发现
- 异常P波电轴是唯一与缺血性卒中风险独立相关的P波指标(HR 1.84, 95%CI 1.33-2.55)。
- 异常P波电轴的β估计值约为CHA2DS2-VASc变量的两倍,故赋2分。
- P2-CHA2DS2-VASc评分使ARIC队列C统计量从0.60(95%CI 0.51-0.69)提高到0.67(95%CI 0.60-0.75)。
- P2-CHA2DS2-VASc评分使MESA队列C统计量从0.68(95%CI 0.52-0.84)提高到0.75(95%CI 0.60-0.91)。
- ARIC和MESA的分类净重分类改善分别为0.25(95%CI 0.13-0.39)和0.51(95%CI 0.18-0.86),相对综合判别改善分别为1.19(95%CI 0.96-1.44)和0.82(95%CI 0.36-1.39)。
关键数值与推荐
- 异常P波电轴定义为P波电轴异常,赋2分加入CHA2DS2-VASc评分形成P2-CHA2DS2-VASc评分。
- P2-CHA2DS2-VASc评分用于预测房颤相关缺血性卒中,尤其在未抗凝的房颤患者中。
临床怎么用
- 对于房颤患者,可考虑测量P波电轴以识别卒中高危个体。
- P2-CHA2DS2-VASc评分可作为CHA2DS2-VASc评分的补充工具,优化卒中风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In people with atrial fibrillation (AF), periods of sinus rhythm present an opportunity to detect prothrombotic atrial remodeling through measurement of P-wave indices (PWIs)-prolonged P-wave duration, abnormal P-wave axis, advanced interatrial block, and abnormal P-wave terminal force in lead V1. We hypothesized that the addition of PWIs to the CHA2DS2-VASc score would improve its ability to predict AF-related ischemic stroke. METHODS: We included 2229 participants from the ARIC study (Atherosclerosis Risk in Communities) and 700 participants from MESA (Multi-Ethnic Study of Atherosclerosis) with incident AF who were not on anticoagulants within 1 year of AF diagnosis. PWIs were obtained from study visit ECGs before development of AF. AF was ascertained using study visit ECGs and hospital records. Ischemic stroke cases were based on physician adjudication of hospital records. We used Cox proportional hazards models to estimate hazard ratios and 95% CIs of PWIs for ischemic stroke. Improvement in 1-year stroke prediction was assessed by C-statistic, categorical net reclassification improvement, and relative integrated discrimination improvement. RESULTS: Abnormal P-wave axis was the only PWI associated with increased ischemic stroke risk (hazard ratio, 1.84; 95% CI, 1.33-2.55) independent of CHA2DS2-VASc variables, and that resulted in meaningful improvement in stroke prediction. The β estimate was approximately twice that of the CHA2DS2-VASc variables, and thus abnormal P-wave axis was assigned 2 points to create the P2-CHA2DS2-VASc score. This improved the C-statistic (95% CI) from 0.60 (0.51-0.69) to 0.67 (0.60-0.75) in ARIC and 0.68 (0.52-0.84) to 0.75 (0.60-0.91) in MESA (validation cohort). In ARIC and MESA, the categorical net reclassification improvements (95% CI) were 0.25 (0.13-0.39) and 0.51 (0.18-0.86), respectively, and the relative integrated discrimination improvement (95% CI) were 1.19 (0.96-1.44) and 0.82 (0.36-1.39), respectively. CONCLUSIONS: Abnormal P-wave axis-an ECG correlate of left atrial abnormality- improves ischemic stroke prediction in AF. Compared with CHA2DS2-VASc, the P2-CHA2DS2-VASc is a better prediction tool for AF-related ischemic stroke.
引用
- Maheshwari A, Norby FL, Roetker NS, et al. Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score. Circulation. 2019. PMID: 30586710. doi:10.1161/CIRCULATIONAHA.118.035411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。